Eagle Pharmaceuticals
EGRX
#9838
Rank
$9.27 M
Marketcap
$0.72
Share price
-1.28%
Change (1 day)
-91.75%
Change (1 year)

Earnings for Eagle Pharmaceuticals (EGRX)

Earnings in 2023 (TTM): $35.65 Million USD

According to Eagle Pharmaceuticals 's latest financial reports the company's current earnings are $0.25 Billion USD. In 2022 the company made an earning of $65.87 Million USD, an increase over its 2021 earnings that were of -$2.92 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eagle Pharmaceuticals from 2013 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) $35.65 M-45.87%
2022 $65.87 M-2361.45%
2021 -$2.92 Million-111.53%
2020 $25.25 M2.31%
2019 $24.68 M-32.89%
2018 $36.77 M-50.35%
2017 $74.08 M38.63%
2016 $53.43 M1966.43%
2015 $2.58 M-111.46%
2014 -$22.58 Million282.82%
2013 -$5.9 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
$18.39 B 51,485.85%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.17 B 11,596.54%๐Ÿ‡ฌ๐Ÿ‡ง UK
$12.73 B 35,604.87%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$0.82 B 2,219.19%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
$4.67 B 13,021.51%๐Ÿ‡บ๐Ÿ‡ธ USA
$10.15 B 28,365.46%๐Ÿ‡บ๐Ÿ‡ธ USA
-$6.88 Billion-19,393.87%๐Ÿ‡บ๐Ÿ‡ธ USA